Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'removedCountries': ['Czechia', 'India', 'Poland', 'Russia']}, 'conditionBrowseModule': {'meshes': [{'id': 'D003324', 'term': 'Coronary Artery Disease'}], 'ancestors': [{'id': 'D003327', 'term': 'Coronary Disease'}, {'id': 'D017202', 'term': 'Myocardial Ischemia'}, {'id': 'D006331', 'term': 'Heart Diseases'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D001161', 'term': 'Arteriosclerosis'}, {'id': 'D001157', 'term': 'Arterial Occlusive Diseases'}, {'id': 'D014652', 'term': 'Vascular Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000077144', 'term': 'Clopidogrel'}], 'ancestors': [{'id': 'D013988', 'term': 'Ticlopidine'}, {'id': 'D058924', 'term': 'Thienopyridines'}, {'id': 'D013876', 'term': 'Thiophenes'}, {'id': 'D013457', 'term': 'Sulfur Compounds'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D011725', 'term': 'Pyridines'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D006574', 'term': 'Heterocyclic Compounds, 2-Ring'}, {'id': 'D000072471', 'term': 'Heterocyclic Compounds, Fused-Ring'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE4'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 4005}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'ACTIVE_NOT_RECRUITING', 'startDateStruct': {'date': '2008-09'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2014-10', 'completionDateStruct': {'date': '2014-11', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2014-10-08', 'studyFirstSubmitDate': '2008-04-15', 'studyFirstSubmitQcDate': '2008-04-17', 'lastUpdatePostDateStruct': {'date': '2014-10-09', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2008-04-18', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2014-11', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Composite of death, myocardial infarction, stent thrombosis, stroke or TIMI major bleeding.', 'timeFrame': '9 months after randomization'}], 'secondaryOutcomes': [{'measure': 'The individual components of the primary endpoint', 'timeFrame': '9 months after randomization'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Clopidogrel', 'Drug-eluting stent'], 'conditions': ['Coronary Artery Disease']}, 'referencesModule': {'references': [{'pmid': '25616646', 'type': 'DERIVED', 'citation': 'Schulz-Schupke S, Byrne RA, Ten Berg JM, Neumann FJ, Han Y, Adriaenssens T, Tolg R, Seyfarth M, Maeng M, Zrenner B, Jacobshagen C, Mudra H, von Hodenberg E, Wohrle J, Angiolillo DJ, von Merzljak B, Rifatov N, Kufner S, Morath T, Feuchtenberger A, Ibrahim T, Janssen PW, Valina C, Li Y, Desmet W, Abdel-Wahab M, Tiroch K, Hengstenberg C, Bernlochner I, Fischer M, Schunkert H, Laugwitz KL, Schomig A, Mehilli J, Kastrati A; Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Trial Investigators. ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. Eur Heart J. 2015 May 21;36(20):1252-63. doi: 10.1093/eurheartj/ehu523. Epub 2015 Jan 23.'}]}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to determine whether a 6 month duration of clopidogrel therapy after DES implantation is not inferior to that of a 12 month therapy.', 'detailedDescription': 'Drug elution from stent struts is associated with less smooth muscle cell proliferation and delayed stent strut re-endothelialization. Thus it seems conceivable that a longer duration of dual antiplatelet therapy (aspirin and clopidogrel) after DES implantation is needed. However, no studies have been done to investigate which is the optimal antiplatelet therapy duration after DES implantation. Therefore, the objective of the randomized, double-blind, placebo-controlled ISAR-SAFE study is to evaluate the safety and efficacy of a 6 month versus a 12 month duration of clopidogrel therapy after DES implantation.\n\nPatients on clopidogrel therapy at least 6 months after DES implantation, who do not require a reintervention will be randomized to an additional 6 month period of clopidogrel or placebo. The patients will be followed-up for 9 months after randomization.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Patients on clopidogrel therapy at 6 months (-1/+2 months) after DES implantation\n* Informed, written consent by the patient\n\nExclusion Criteria:\n\n* Age ≤18 years\n* Clinically symptoms, proof of ischemia and/or presence of angiographic lesions requiring revascularization\n* Previous stent thrombosis\n* DES in left main coronary artery\n* ST-elevation and non-ST-elevation myocardial infarction during the last 6 months\n* Malignancies or other comorbid conditions with a life expectancy of less than one year or that may result in protocol noncompliance\n* Planned major surgery within the next 6 months with the need to discontinue antiplatelet therapy\n* Active bleeding; bleeding diathesis; history intracranial bleeding\n* Oral anticoagulation therapy with coumadin derivatives\n* Known allergy or intolerance to the study medications: aspirin and clopidogrel\n* Pregnancy (present, suspected or planned) or positive pregnancy test (In women with childbearing potential a negative pregnancy test is mandatory)\n* Patient's inability to fully comply with the study protocol\n* Prior enrollment in the same clinical trial."}, 'identificationModule': {'nctId': 'NCT00661206', 'acronym': 'ISAR-SAFE', 'briefTitle': 'Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting', 'organization': {'class': 'OTHER', 'fullName': 'Deutsches Herzzentrum Muenchen'}, 'officialTitle': 'Randomized, Double-Blind, Placebo-controlled Trial of 6 vs. 12 Months Clopidogrel Therapy After Implantation of a Drug-Eluting Stent', 'orgStudyIdInfo': {'id': 'GE IDE No. A01207'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Clopidogrel', 'interventionNames': ['Drug: Clopidogrel']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'interventionNames': ['Drug: Placebo']}], 'interventions': [{'name': 'Clopidogrel', 'type': 'DRUG', 'otherNames': ['Plavix', 'ACT-Code: B01AC/04'], 'description': 'Patients on clopidogrel therapy at 6 months after implantation of a drug-eluting stent will be randomized to an additional 6 month period of clopidogrel 75mg per day', 'armGroupLabels': ['Clopidogrel']}, {'name': 'Placebo', 'type': 'DRUG', 'description': 'Patients randomized in this group will receive placebo for 6 months.', 'armGroupLabels': ['Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': '32209', 'city': 'Jacksonville', 'state': 'Florida', 'country': 'United States', 'facility': 'University of Florida, Health Science Center - Jacksonville', 'geoPoint': {'lat': 30.33218, 'lon': -81.65565}}, {'city': 'Tirana', 'country': 'Albania', 'facility': 'Spitali Gjerman', 'geoPoint': {'lat': 41.32744, 'lon': 19.81866}}, {'zip': '1030', 'city': 'Vienna', 'country': 'Austria', 'facility': 'Krankenanstalt Rudolfstiftung', 'geoPoint': {'lat': 48.20849, 'lon': 16.37208}}, {'zip': '1160', 'city': 'Vienna', 'country': 'Austria', 'facility': 'Wilhelminenspital Wien', 'geoPoint': {'lat': 48.20849, 'lon': 16.37208}}, {'zip': '3000', 'city': 'Leuven', 'country': 'Belgium', 'facility': 'University Hospitals Leuven', 'geoPoint': {'lat': 50.87959, 'lon': 4.70093}}, {'zip': '110016', 'city': 'Shenyang', 'country': 'China', 'facility': 'Shenyang Northern Hospital', 'geoPoint': {'lat': 41.79222, 'lon': 123.43278}}, {'zip': '8200', 'city': 'Aarhus', 'country': 'Denmark', 'facility': 'Aarhus University Hospital', 'geoPoint': {'lat': 56.15674, 'lon': 10.21076}}, {'zip': '79189', 'city': 'Bad Krozingen', 'country': 'Germany', 'facility': 'Herzzentrum Bad Krozingen', 'geoPoint': {'lat': 47.91667, 'lon': 7.7}}, {'zip': '23795', 'city': 'Bad Segeberg', 'country': 'Germany', 'facility': 'Segeberger Kliniken GmbH', 'geoPoint': {'lat': 53.93775, 'lon': 10.30745}}, {'zip': '12203', 'city': 'Berlin', 'country': 'Germany', 'facility': 'Charité Berlin, Campus Benjamin Franklin', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '01309', 'city': 'Dresden', 'country': 'Germany', 'facility': 'Technische Universität Dresden', 'geoPoint': {'lat': 51.05089, 'lon': 13.73832}}, {'zip': '91054', 'city': 'Erlangen', 'country': 'Germany', 'facility': 'Universitätsklinikum Erlangen', 'geoPoint': {'lat': 49.59099, 'lon': 11.00783}}, {'zip': '82467', 'city': 'Garmisch-Partenkirchen', 'country': 'Germany', 'facility': 'Klinikum Garmisch-Partenkirchen', 'geoPoint': {'lat': 47.49209, 'lon': 11.09576}}, {'zip': '37075', 'city': 'Göttingen', 'country': 'Germany', 'facility': 'Universitätsmedizin Göttingen', 'geoPoint': {'lat': 51.53443, 'lon': 9.93228}}, {'zip': '85049', 'city': 'Ingolstadt', 'country': 'Germany', 'facility': 'Klinikum Ingolstadt', 'geoPoint': {'lat': 48.76508, 'lon': 11.42372}}, {'zip': '77933', 'city': 'Lahr', 'country': 'Germany', 'facility': 'MediClin Herzzentrum Lahr/Baden', 'geoPoint': {'lat': 48.34042, 'lon': 7.86886}}, {'zip': '84036', 'city': 'Landshut', 'country': 'Germany', 'facility': 'Krankenhaus Landshut-Achdorf', 'geoPoint': {'lat': 48.52961, 'lon': 12.16179}}, {'zip': '04289', 'city': 'Leipzig', 'country': 'Germany', 'facility': 'Herzzentrum Leipzig', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '23538', 'city': 'Lübeck', 'country': 'Germany', 'facility': 'Universitätsklinikum Schleswig-Holstein, Campus Lübeck', 'geoPoint': {'lat': 53.86893, 'lon': 10.68729}}, {'zip': '81541', 'city': 'Munich', 'country': 'Germany', 'facility': 'Deutsches Herzzentrum München', 'geoPoint': {'lat': 48.13743, 'lon': 11.57549}}, {'zip': '81675', 'city': 'Munich', 'country': 'Germany', 'facility': '1st Medizinische Klinik, Klinikum rechts der Isar', 'geoPoint': {'lat': 48.13743, 'lon': 11.57549}}, {'zip': '81925', 'city': 'Munich', 'country': 'Germany', 'facility': 'Klinikum Bogenhausen', 'geoPoint': {'lat': 48.13743, 'lon': 11.57549}}, {'zip': '81377', 'city': 'München', 'country': 'Germany', 'facility': 'Klinikum München-Großhadern', 'geoPoint': {'lat': 51.60698, 'lon': 13.31243}}, {'zip': '81737', 'city': 'München', 'country': 'Germany', 'facility': 'Städtisches Klinikum München-Neuperlach', 'geoPoint': {'lat': 51.60698, 'lon': 13.31243}}, {'zip': '41464', 'city': 'Neuss', 'country': 'Germany', 'facility': 'Lukaskrankenhaus GmbH, Städtische Kliniken Neuss', 'geoPoint': {'lat': 51.19807, 'lon': 6.68504}}, {'zip': '93042', 'city': 'Regensburg', 'country': 'Germany', 'facility': 'Universitätsklinikum Regensburg', 'geoPoint': {'lat': 49.01513, 'lon': 12.10161}}, {'zip': '93049', 'city': 'Regensburg', 'country': 'Germany', 'facility': 'Klinikum Barmherzige Brüder Regensburg', 'geoPoint': {'lat': 49.01513, 'lon': 12.10161}}, {'zip': '18057', 'city': 'Rostock', 'country': 'Germany', 'facility': 'Universitätsklinik Rostock', 'geoPoint': {'lat': 54.0887, 'lon': 12.14049}}, {'zip': '89081', 'city': 'Ulm', 'country': 'Germany', 'facility': 'Universitätsklinikum Ulm', 'geoPoint': {'lat': 48.39841, 'lon': 9.99155}}, {'zip': '42117', 'city': 'Wuppertal', 'country': 'Germany', 'facility': 'HELIOS Klinikum Wuppertal-Herzzentrum', 'geoPoint': {'lat': 51.25627, 'lon': 7.14816}}, {'city': 'Galway', 'country': 'Ireland', 'facility': 'University College Hospital Galway', 'geoPoint': {'lat': 53.27245, 'lon': -9.05095}}, {'zip': '00128', 'city': 'Rome', 'country': 'Italy', 'facility': 'Campus Biomedico University of Rome', 'geoPoint': {'lat': 41.89193, 'lon': 12.51133}}, {'zip': '259 - 1193', 'city': 'Isehara', 'country': 'Japan', 'facility': 'Tokai University School of Medicine', 'geoPoint': {'lat': 35.39932, 'lon': 139.31019}}, {'zip': '606-8507', 'city': 'Kyoto', 'country': 'Japan', 'facility': 'Kyoto University Hospital', 'geoPoint': {'lat': 35.02107, 'lon': 135.75385}}, {'zip': '5623', 'city': 'Eindhoven', 'country': 'Netherlands', 'facility': 'Catharina Hospital Eindhoven', 'geoPoint': {'lat': 51.44083, 'lon': 5.47778}}, {'zip': '3435', 'city': 'Nieuwegein', 'country': 'Netherlands', 'facility': 'St. Antonius Hospital Department of Cardiology', 'geoPoint': {'lat': 52.02917, 'lon': 5.08056}}, {'zip': '3075', 'city': 'Rotterdam', 'country': 'Netherlands', 'facility': 'Maasstad Ziekenhuis', 'geoPoint': {'lat': 51.9225, 'lon': 4.47917}}, {'zip': '8011', 'city': 'Zwolle', 'country': 'Netherlands', 'facility': 'Isala klinieken, locatie Weezenlanden', 'geoPoint': {'lat': 52.5125, 'lon': 6.09444}}, {'zip': '1023', 'city': 'Auckland', 'country': 'New Zealand', 'facility': 'Auckland City Hospital', 'geoPoint': {'lat': -36.84853, 'lon': 174.76349}}, {'zip': '3010', 'city': 'Bern', 'country': 'Switzerland', 'facility': 'Inselspital, Universitätsspital Bern', 'geoPoint': {'lat': 46.94809, 'lon': 7.44744}}], 'overallOfficials': [{'name': 'Adnan Kastrati, MD', 'role': 'STUDY_CHAIR', 'affiliation': 'Deutsches Herzzentrum Muenchen'}, {'name': 'Adnan Kastrati, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Deutsches Herzzentrum Muenchen'}, {'name': 'Jurriёn M ten Berg, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'St. Antonius Hospital Nieuwegein, Department of Cardiology'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Deutsches Herzzentrum Muenchen', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}